10 lakh testing kits per month to be produced by India

NEW DELHI: India is ready to maufacture 10 lakh kits per month each of RT-PCR testing and rapid antibody detection tests for noverl coronavirus from May, the production will reduce dependency on imports amid increase in demand globally caused by the pandemic.

Efforts in areas of diagnostics, therapeutics and vaccines are also being monitored on a war footing, health ministry said. The present ventilator manufacturing capacity in India is 6,000 a month.

Health ministry joint secretary Lav Agarwal said,“Production of ancillary support devices such as personal protective equipment, oxygen concentrators, ventilators, CSIR engineering labs is being augmented by indigenous designs of Sree Chitra Tiurumalai Institute of Medical Science and Technology (SCTIMST) under Department of Science and Technology.”

Till Friday, a total 1,919 dedicated Covid-19 facilities were identified across the country with 1,73,746 isolation beds and 21,806 ICU beds. The 1,919 facilities include 672 dedicated Covid hospitals for serious patients needing tertiary care and 1,247 dedicated Covid healthcare centres for patients with moderate symptoms.

  • Related Posts

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?